Theralase® Bladder Cancer Clinical Study
Our anti-cancer technology has now successfully completed a Phase 1b Clinical Study for Non-Muscle Invasive Bladder Cancer ("NMIBC"). We are currently designing a Phase II Non-Muscle Invasive Bladder Cancer Clinical Study.
In the following video Dr. Girish Kulkarni MD, Surgeon-scientist affiliated with the Department of Surgery, Faculty of Medicine at the University of Toronto discusses the successful completion of this clinical study.
Our Partners in Innovation